BILL ANALYSIS Ó
ACR 26
Page 1
Date of Hearing: April 7, 2011
ASSEMBLY COMMITTEE ON RULES
Nancy Skinner, Chair
ACR 26 (Galgiani) - As Introduced: February 18, 2011
SUBJECT : Chronic obstructive pulmonary disease awareness.
SUMMARY : Encourages the State Department of Health Care
Services to, whenever possible, partner with private entities to
improve education regarding Chronic obstructive pulmonary
disease (COPD); declares November 2011, as Chronic Obstructive
Pulmonary Disease Awareness Month in California; and encourages
public officials and the citizens of California to increase
awareness about the symptoms of, and the methods of, preventing
COPD. Specifically, this resolution makes the following
legislative findings:
1)COPD, also known as chronic bronchitis and emphysema, is the
fourth leading cause of death in the United States; and, its
prevalence and death rate is rising.
2)COPD is a chronic and progressive disease that impacts an
estimated 24 million Americans each year; and, many patients
suffering with COPD are not diagnosed until they have reached
an advanced state which often includes a disabling degree of
lung dysfunction.
3)Early diagnosis and management of COPD can lead to an improved
quality of life and self-sufficiency for patients who receive
publicly funded benefits, including Medi-Cal; and a diagnostic
test for COPD, known as spirometry, is available for office
use, allowing early diagnosis of COPD.
4)The "Healthy People 2010" project of the Centers for Disease
Control and Prevention and the National Institutes of Health
concludes that primary care physicians are in key position to
provide optimal care to patients with COPD; and they need to
be trained in the latest methods for diagnosing and treating
the disease.
FISCAL EFFECT : None
REGISTERED SUPPORT / OPPOSITION :
ACR 26
Page 2
Support
Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI)
Talecris Biotherapeutics
Opposition
None on file.
Analysis Prepared by : Anna McCabe / RLS. / (916) 319-2800